Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine

This study has been completed.
Sponsor:
Information provided by:
Gachon University Gil Medical Center
ClinicalTrials.gov Identifier:
NCT01184560
First received: August 16, 2010
Last updated: August 18, 2010
Last verified: October 2009